BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

BIOBIJOU Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	34,001	29,633	17,130
Revenue Growth (YoY)	-	72.99%	-
Cost of Revenue	16,149	14,815	8,871
Gross Profit	17,852	14,819	8,259
Selling, General & Admin	6,644	3,982	2,311
Research & Development	766.15	1,213	632.7
Other Operating Expenses	58.82	47.52	29.74
Operating Expenses	7,857	5,592	3,094
Operating Income	9,994	9,227	5,165
Interest Expense	-145.43	-444.24	-594.63
Interest & Investment Income	127.33	205.4	126.48
Currency Exchange Gain (Loss)	-503.26	765.23	400.31
Other Non Operating Income (Expenses)	10.31	-922.33	-949.25
EBT Excluding Unusual Items	9,483	8,831	4,148
Gain (Loss) on Sale of Investments	181.4	148.3	79.14
Gain (Loss) on Sale of Assets	-	-	0.65
Pretax Income	9,665	8,979	4,227
Income Tax Expense	1,850	1,791	917.41
Net Income	7,814	7,188	3,310
Net Income to Common	7,814	7,188	3,310
Net Income Growth	-	117.16%	-
Shares Outstanding (Basic)	12	11	11
Shares Outstanding (Diluted)	12	11	11
Shares Change (YoY)	-	6.20%	-
EPS (Basic)	632.31	630.08	308.13
EPS (Diluted)	632.31	630.08	308.13
EPS Growth	-	104.48%	-
Free Cash Flow	5,891	461.05	4,038
Free Cash Flow Per Share	476.65	40.41	375.87
Gross Margin	52.50%	50.01%	48.21%
Operating Margin	29.39%	31.14%	30.15%
Profit Margin	22.98%	24.26%	19.32%
Free Cash Flow Margin	17.32%	1.56%	23.57%
EBITDA	10,748	9,927	5,752
EBITDA Margin	31.61%	33.50%	33.58%
D&A For EBITDA	753.78	700.16	587.04
EBIT	9,994	9,227	5,165
EBIT Margin	29.39%	31.14%	30.15%
Effective Tax Rate	19.14%	19.95%	21.70%
Advertising Expenses	-	469.22	188.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.